SEC Form 4 · accession 0001193125-26-386838
RxSight, Inc. · RXST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald M Kurtz M.D.
Officer — Chief Medical Officer
Period of report
Sep 5, 2026
Accepted (ET)
Sep 9, 2026 · 8:53 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001111485
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $16.00 | Sep 5, 2026 | D | 338,819 | D | Jul 30, 2025 | Jul 30, 2031 | Common Stock | 338,819 | 0 | D |
| Stock Option (right to buy)F3,F2 | $14.95 | Sep 5, 2026 | D | 200,000 | D | — | Mar 8, 2033 | Common Stock | 200,000 | 0 | D |
| Stock Option (right to buy)F5,F4 | $56.07 | Sep 5, 2026 | D | 149,000 | D | — | Mar 3, 2034 | Common Stock | 149,000 | 0 | D |
| Stock Option (right to buy)F1,F6 | $28.21 | Sep 5, 2026 | D | 215,000 | D | — | Feb 26, 2035 | Common Stock | 215,000 | 0 | D |
| Stock Option (right to buy)F1,F7 | $6.375 | Sep 5, 2026 | A | 254,751 | A | — | Sep 4, 2033 | Common Stock | 254,751 | 254,751 | D |
| Stock Option (right to buy)F3,F8 | $6.375 | Sep 5, 2026 | A | 173,913 | A | — | Sep 4, 2033 | Common Stock | 173,913 | 173,913 | D |
| Stock Option (right to buy)F5,F9 | $6.375 | Sep 5, 2026 | A | 96,129 | A | — | Sep 4, 2033 | Common Stock | 96,129 | 96,129 | D |
| Stock Option (right to buy)F1,F10 | $6.375 | Sep 5, 2026 | A | 161,654 | A | — | Sep 4, 2033 | Common Stock | 161,654 | 161,654 | D |
Explanation of responses
- F1On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share.
- F10Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,620 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,620 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 101,034 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
- F2Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023.
- F3On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share.
- F4Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024.
- F5On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share.
- F6Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025.
- F7Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027.
- F8Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 148,549 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 148,549 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 25,364 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
- F9Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,080 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,080 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 36,049 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.